ANTIBACTERIAL ACTIVITY OF BOSWELLIA SERRATA ROXB. EX COLEBR. ETHANOMEDICINAL PLANT AGAINST GRAM NEGATIVE UTI PATHOGENS

  • N. B. PATEL* 1 AND K.C. PATEL 2 1. SMT. S. S. PATEL NOOTAN SCIENCE AND COMMERCE COLLEGE, VISNAGAR, GUJARAT, INDIA. 2. P. G. CENTRE OF BOTANY, SMT. S. M. PANCHAL SCIENCE COLLEGE, TALOD, GUJARAT, INDIA. Corresponding author’s e-mail: niks17micro@gmail.com

Abstract

The gum exuded from stem of Boswellia serrata (Family: Burseraceae), used in traditional medicine for the therapeutic purpose was extracted by aqueous, petroleum ether, acetone and methanol. The disc diffusion method was used to determine the antibacterial activity on gram negative: Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, and Klebsiella pneumoniae UTI pathogens. The results indicated that the Aqueous extract of B. serrata showed high zone of inhibition against P. vulgaris (22.67 mm), Petroleum ether extract of B. serrata showed high zone of inhibition against gram negative organism P. aeruginosa (21 mm), Methanol extract of B. serrata showed high zone of inhibition against P. vulgaris (18 mm), Acetone extract of B. serrata showed high zone of inhibition against P. aeruginosa (18 mm). The acetone extract of Boswellia serrata plant displayed an excellent antibacterial activity against E.coli and K. pneumoniae with MIC value 12.5µg/µl, The methanol extract of Boswellia serrata plant displayed a good antibacterial activity against E.coli, P. aeruginosa and P. vulgaris with MIC value 25µg/µl, The aqueous extract of Boswellia serrata gum displayed an excellent antibacterial activity against P. aeruginosa and P. vulgaris with MIC value 12.5µg/µl, The petroleum ether extract of Boswellia serrata plant displayed an excellent antibacterial activity against P. aeruginosa with MIC value 12.5µg/µl.

References

Akharaiyi, F. C. and Boboye, B. 2010. Antibacterial and Phytochemical Evaluation of Three Medicinal Plants, Jour. of Natural Products, 3:27-34.
Andrews, J. M. 2001. Determination of minimum inhibitory concentration, Jour. of Antimicrobial Chemotherapy, 48 (S1):5-16.
Anthoni, C., Laukoetter, M. G., Rijcken, E., Vowinkel, T., Mennigen, R., Muller, S., Senninger, N., Russell, J., Jauch, J., Bergmann, J., Granger, D. N., Krieglstein, C. F. 2006. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis, Am J Physiol Gastrointest Liver Physiol., 290:G1131-G1137.
Baur, A. W., Kirby, W. M., Sherris, J. C, Turck, M. 1966. Antibiotic susceptibility testing by a standard single disk method, Am. J. Clin. Path., 45:493-496.
Gerhardt, H., Seifert, F., Buvari, P., Vogelsang, H., Repges, R. 2001. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol, 39:11–17.
Ghosh, A., Das, B. K., Roy, A., Mandal, B., Chandra, G. 2008. Antibacterial activity of some medicinal plant extracts, J. Nat. Med., 62:259-262.
Glaser, T., Winter, S., Groscurth, P., Safayhi, H., Sailer, E. R., Ammon, H. P., Schabet, M., Weller, M. 1999. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity, Br. J. Cancer, 80:756-765.
Guerin-Faublee, V., Muller, M. L. D., Vigneulle, M., Flandrois, J. P. 1996. Application of a modified disc diffusion technique to antimicrobial susceptibility testing of Vibrio anguillarum and Aeromonas salmonicida clinical isolates, Veterinary Micro., 51:137-149.
Gupta, I., Gupta, V., Parihar, A., Gupta, S., Ludtke, R., Safayhi, H., Ammon, H. P. 1998. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study, Eur. J. Med. Res., 3:511-514.
Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Ludtke, R., Safayhi, H., Ammon, H. P. 2001. Effects of gum resin of Boswellia serrata in subjects with chronic colitis, Planta Med., 67:391-395.
Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Ludtke, R., Safayhi, H., Ammon, H. P. 1997. Effects of Boswellia serrata gum resin in patients with ulcerative colitis, Eur. J. Med. Res., 2:37-43.
Han, R. 1994. Highlight on the studies of anticancer drugs derived from plants in China. Stem. Cells, 12:53-63.
Han, R. 1994. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China, Chin. Med. Sci. J., 9:61-69.
Hoernlein, R. F., Orlikowsky, T., Zehrer, C., Niethammer, D., Sailer, E. R., Simmet, T., Dannecker, G. E., Ammon, H. P. 1999. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I, J. Pharmacol. Exp. Ther., 288:613-619.
Janssen, G., Bode, U., Breu, H., Dohrn, B., Engelbrecht, V., Gobel, U. 2000. Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors, Klin. Padiatr, 212:189-195.
Jian-Jun, L., Baohua, H., Shing, C. H. 2006. Acetyl-keto-β-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells, Br. J. Pharmacol., 148(8):1099-1107.
Jing, Y., Nakajo, S., Xia, L., Nakaya, K., Fang, Q., Waxman, S., Han, R. 1999. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines, Leuk. Res., 23: 43-50.
Joos, S., Rosemann, T., Szecsenyi, J., Hahn, E. G., Willich, S. N., Brinkhaus, B. 2006. Use of complementary and alternative medicine in Germany- a survey of subjects with inflammatory bowel disease, BMC Complement Altern Med., 6:19.
Kiela, P. R., Midura, A. J., Kuscuoglu, N., Jolad, S. D., Solyom, A. M., Besselsen, D. G., Timmermann, B. N., Ghishan, F. K. 2005. Effects of Boswellia serrata in mouse models of chemically induced colitis, Am. J. Physiol. Gastrointest. Liver Physiol., 288:G798-G808.
Kimmatkar, N., Thawani, V., Hingorani, L., Khiyani, R. 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial, Phytomed., 10:3-7.
Kokate, C. K., Purohit, A. P., Gokhle, S. B., 2007. Pharmacognosy, nirali prakashan, pune, 37:105-108.
Liu, J. J., Nilsson, A., Oredsson, S., Badmaev, V., Duan, R. D. 2002. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway, Int. J. Mol. Med., 10:501-505.
Mohamed, S. S. H., Hansi, P. D., Kavitha, T. 2010. Antimicrobial activity and phytochemical analysis of selected Indian folk medicinal plants, Inter. Jour. of Pharma. Sci. and Res., 1(10):430-434.
Omogbai, B. A. and Eze, F. A. 2011. Phytochemical Screening and Susceptibility of Bacteria Pathogens to Extracts of Evolvulus alsinoides, Sci. World Jour., 6 (1):5-8.
Park, Y. S., Lee, J. H., Harwalkar, J. A., Bondar, J., Safayhi, H., Golubic, M. 2002. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2, Adv. Exp. Med. Biol., 507:387-393.
Raja, A. F, Ali, F., Khan, I. A, Shawl, A. S, Arora, D. S, Shah, B. A., Taneja, S. C. 2011. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata, BMC Micro., 11:54.
Raja, A. F., Ali, F., Khan, I. A., Shawl, A. S., Arora, D. S. 2011, Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens, BMC Res. Notes, 4:406.
Safayhi, H., Mack, T., Ammon, H. P. (1991). Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice, Biochem. Pharmacol. 41:1536-1537.
Safayhi, H., Mack, T., Sabieraj, J., Anazodo, M. I., Subramanian, L. R., Ammon, H. P. T. 1992. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase, J Pharmacol Exp Ther., 26:1143-1146.
Sailer, E. R., Subramanian, L. R., Rall, B., Hoernlein, R. F., Ammon, H. P. T., Safayhi, H. 1996. Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements or binding and 5-lipoxygenase inhibitory activity, Br J Pharmacol., 117:615-618.
Shao, Y., Ho, C. T., Chin, C. K., Badmaev, V., Ma, W., Huang, M. T. 1998. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture, Planta. Med., 64:328-331.
Streffer, J. R., Bitzer, M., Schabet, M., Dichgans, J., Weller, M. 2001. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15, Neurology, 56:1219-1221.
Sundaram, S., Dwivedi, P., Purwar, S. 2011. Antibacterial Activities of Crude Extracts of Chlorophytum borivilianum to Bacterial Pathogens, Res. Jour. of Medi. Plant, 5:343-347.
Syrovets, T., Gschwend, J. E., Buchele, B., Laumonnier, Y., Zugmaier, W., Genze, F., Simmet, T. 2005. Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo, J. Biol. Chem., 280:6170-6180.
Winking, M., Sarikaya, S., Rahmanian, A., Jodicke, A., Boker, D. K. 2000. Boswellic acids inhibit glioma growth: a new treatment option, J. Neurooncol., 46:97-103.
Zaidan, M. R. S., Rain, N. A., Badrul, A. R., Adlin, A., Norazah, A., Zakiah, I. 2005. In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method, Tropical Biomedicine, 22(2):165-170.
Zhao, W., Entschladen, F., Liu, H., Niggemann, B., Fang, Q., Zaenker, K. S., Han, R. 2003. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells, Cancer Detect. Prev., 27:67-75.
How to Cite
K.C. PATEL 2, N. B. PATEL* 1 AND. ANTIBACTERIAL ACTIVITY OF BOSWELLIA SERRATA ROXB. EX COLEBR. ETHANOMEDICINAL PLANT AGAINST GRAM NEGATIVE UTI PATHOGENS. LIFE SCIENCES LEAFLETS, [S.l.], v. 53, june 2014. ISSN 0976-1098. Available at: <http://petsd.org/ojs/index.php/lifesciencesleaflets/article/view/119>. Date accessed: 16 aug. 2017.

Keywords

Boswellia serrata, antibacterial, disc diffusion, Minimum Inhibitory Concentration (MIC).